95 related articles for article (PubMed ID: 38660492)
1. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
2. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.
Song W; Li Y; Yao Y; Sun S; Guan X; Wang B
BMC Cancer; 2024 Jun; 24(1):680. PubMed ID: 38834983
[TBL] [Abstract][Full Text] [Related]
3. Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes.
Liu Z; Peng Z; Lin H; Zhou K; Liang L; Cao J; Huang Z; Mei J
Respir Res; 2024 May; 25(1):217. PubMed ID: 38783236
[TBL] [Abstract][Full Text] [Related]
4. Potential marker genes for chronic obstructive pulmonary disease revealed based on single-cell sequencing and Mendelian randomization analysis.
Sun G; Zhou Y; Han X; Che X; Yu S; Song D; Ma F; Huang L
Aging (Albany NY); 2024 May; 16(10):8922-8943. PubMed ID: 38787375
[TBL] [Abstract][Full Text] [Related]
5. Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis.
Dai L; Ye Y; Mugaany J; Hu Z; Huang J; Lu C
Aging (Albany NY); 2024 May; 16(10):9228-9250. PubMed ID: 38809509
[TBL] [Abstract][Full Text] [Related]
6. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.
Zhang Y; Liu W; Lai J; Zeng H
Front Immunol; 2024; 15():1394438. PubMed ID: 38835753
[TBL] [Abstract][Full Text] [Related]
7. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
8. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
[TBL] [Abstract][Full Text] [Related]
9. Single-cell and genome-wide Mendelian randomization identifies causative genes for gout.
Yang Y; Hu P; Zhang Q; Ma B; Chen J; Wang B; Ma J; Liu D; Hao J; Zhou X
Arthritis Res Ther; 2024 Jun; 26(1):114. PubMed ID: 38831441
[TBL] [Abstract][Full Text] [Related]
10. Potential drug targets for gastroesophageal reflux disease and Barrett's esophagus identified through Mendelian randomization analysis.
Lin YL; Yao T; Wang YW; Zhou ZX; Hong ZC; Shen Y; Yan Y; Li YC; Lin JF
J Hum Genet; 2024 Jun; 69(6):245-253. PubMed ID: 38429412
[TBL] [Abstract][Full Text] [Related]
11. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
Yuan W; Xu W; Xu X; Qu B; Zhao F
Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
Wain LV; Shrine N; Artigas MS; Erzurumluoglu AM; Noyvert B; Bossini-Castillo L; Obeidat M; Henry AP; Portelli MA; Hall RJ; Billington CK; Rimington TL; Fenech AG; John C; Blake T; Jackson VE; Allen RJ; Prins BP; ; Campbell A; Porteous DJ; Jarvelin MR; Wielscher M; James AL; Hui J; Wareham NJ; Zhao JH; Wilson JF; Joshi PK; Stubbe B; Rawal R; Schulz H; Imboden M; Probst-Hensch NM; Karrasch S; Gieger C; Deary IJ; Harris SE; Marten J; Rudan I; Enroth S; Gyllensten U; Kerr SM; Polasek O; Kähönen M; Surakka I; Vitart V; Hayward C; Lehtimäki T; Raitakari OT; Evans DM; Henderson AJ; Pennell CE; Wang CA; Sly PD; Wan ES; Busch R; Hobbs BD; Litonjua AA; Sparrow DW; Gulsvik A; Bakke PS; Crapo JD; Beaty TH; Hansel NN; Mathias RA; Ruczinski I; Barnes KC; Bossé Y; Joubert P; van den Berge M; Brandsma CA; Paré PD; Sin DD; Nickle DC; Hao K; Gottesman O; Dewey FE; Bruse SE; Carey DJ; Kirchner HL; ; Jonsson S; Thorleifsson G; Jonsdottir I; Gislason T; Stefansson K; Schurmann C; Nadkarni G; Bottinger EP; Loos RJ; Walters RG; Chen Z; Millwood IY; Vaucher J; Kurmi OP; Li L; Hansell AL; Brightling C; Zeggini E; Cho MH; Silverman EK; Sayers I; Trynka G; Morris AP; Strachan DP; Hall IP; Tobin MD
Nat Genet; 2017 Mar; 49(3):416-425. PubMed ID: 28166213
[TBL] [Abstract][Full Text] [Related]
13. Identifying potential drug targets for varicose veins through integration of GWAS and eQTL summary data.
Cui Y; Hu M; Zhou H; Guo J; Wang Q; Xu Z; Chen L; Zhang W; Tang S
Front Genet; 2024; 15():1385293. PubMed ID: 38818040
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study.
Qu K; Li MX; Yu P; ; Wu BH; Shi M; Dong M
Sci Rep; 2024 May; 14(1):12094. PubMed ID: 38802400
[TBL] [Abstract][Full Text] [Related]
15. Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis.
Tan C; Li Y; Wang K; Lin Y; Chen Y; Zheng X
BMC Med Genomics; 2024 May; 17(1):138. PubMed ID: 38778378
[TBL] [Abstract][Full Text] [Related]
16. A cross-tissue transcriptome-wide association study reveals novel susceptibility genes for migraine.
Gui J; Yang X; Tan C; Wang L; Meng L; Han Z; Liu J; Jiang L
J Headache Pain; 2024 Jun; 25(1):94. PubMed ID: 38840241
[TBL] [Abstract][Full Text] [Related]
17. Identification of pleiotropic and specific therapeutic targets for cardio-cerebral diseases: A large-scale proteome-wide mendelian randomization and colocalization study.
Zhu Y; Wang Y; Cui Z; Liu F; Hu J
PLoS One; 2024; 19(5):e0300500. PubMed ID: 38820305
[TBL] [Abstract][Full Text] [Related]
18. Proteome-Wide Multicenter Mendelian Randomization Analysis to Identify Novel Therapeutic Targets for Lung Cancer.
Wang K; Yi H; Wang Y; Jin D; Zhang G; Mao Y
Arch Bronconeumol; 2024 May; ():. PubMed ID: 38824092
[TBL] [Abstract][Full Text] [Related]
19. Prioritization of therapeutic targets for cancers using integrative multi-omics analysis.
Jin X; Mei Y; Yang P; Huang R; Zhang H; Wu Y; Wang M; He X; Jiang Z; Zhu W; Wang L
Hum Genomics; 2024 Apr; 18(1):42. PubMed ID: 38659038
[TBL] [Abstract][Full Text] [Related]
20. The immune cells have complex causal regulation effects on cancers.
Li M; Shi P; Yang H; Liu S; Sun R; Li L; Zhao Z; Sun J
Int Immunopharmacol; 2024 Jun; 134():112179. PubMed ID: 38710118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
